COVID-19

News

Verona to test COPD hopeful ensifentrine in COVID-19 patient...

Verona Pharma is starting a pilot study of its inhaled respiratory diseases drug ensifentrine in patients hospitalised with COVID-19.

Views & Analysis

Unpleasant truth: the pandemic, record debt and our opportun...

Sandoz’s Pierre Bourdage looks at the unexpected secondary impacts of COVID-19 on countries and healthcare systems, and asks how pharma can help improve sustainability to tackle them.

News

Blood sample with respiratory coronavirus positive

Switzerland's ender to provide rapid COVID-19 diagnostics te...

ender diagnostics, a Swiss firm specialising in rapid molecular biological tests, has announced a collaboration with a national airline to test long-hall cabin crew members for the coronavi

Views & Analysis

Digital success for pharma services in a uncertain world

Laura Morrill from ECI Partners looks at why data and technology are the keys to success in pharma services post-COVID.

News

Coronavirus vaccine: how pharma is picking up the pace

Losing ground in COVID-19 vaccine race, CanSino turns to Rus...

Politicking between China and Canada threatened to slow down development of a coronavirus vaccine from CanSino Biologics, but the company says the project is back on track following regulat

News

Early data shows Russia's Sputnik V COVID-19 vaccine produce...

A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety.

Verona to test COPD hopeful ensifentrine in COVID-19 patient...

Unpleasant truth: the pandemic, record debt and our opportun...

Switzerland's ender to provide rapid COVID-19 diagnostics te...

Digital success for pharma services in a uncertain world

Losing ground in COVID-19 vaccine race, CanSino turns to Rus...

Early data shows Russia's Sputnik V COVID-19 vaccine produce...

UK, pharma industry pilot rapid access routes for medicines

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks